Genetic counselling in mitochondrial diseases

Current Opinion in Neurology

Volumn 10, Issue 5, 1997, Pages 408-412

  Warner, Thomas T ^a   Schapira, Anthony H V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; MITOCHONDRIAL RNA; RIBOSOME DNA; RIBOSOME RNA; TRANSFER RNA;

CELL NUCLEUS; DELETION MUTANT; ENZYME SUBUNIT; ENZYME SYNTHESIS; GENE MUTATION; GENE REARRANGEMENT; GENETIC COUNSELING; HUMAN; MITOCHONDRIAL MYOPATHY; RESPIRATORY CHAIN; REVIEW; RISK ASSESSMENT;

EID: 0030771308     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199710000-00009     Document Type: Review

References (50)

1. Maassen J, Kadowaki T: Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996, 39:375-382.
2. Wallace DC: Diseases of the mitochondrial DNA. Annu Rev Biochem 1992, 61:1171-1212.
3. Johns DR: Mitochondrial DNA and disease. N Engl J Med 1995, 333:638-644.
4. Moraes CT: Mitochondrial disorders. Curr Opin Neurol 1996, 9:369-374.
5. Zeviani M, Fernandez-Silva P, Tiranti V: Disorders of mitochondria and related metabolism. Curr Opin Neurol 1997, 10:160-167.
6. Anderson S, Bankier AT, Barrell BG, De Bruijn ML, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F et al.: Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
7. 4977. Am J Hum Genet 1996, 59:772-780.
8. Attardi G, Yoneda M, Chomyn A: Complementation and segregation behavior of disease causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1995, 1271:241-248.
9. Jenuth JO, Peterson AC, Fu IC, Shoubridge EA: Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nature Genet 1996, 14:146-151 This study of heteroplasmy in mice demonstrated that the pattern of segregation of mitochondrial DNA variants can be explained by random genetic drift in early oogenesis. The effective number of segregating units for mitochondrial DNA was estimated to be approximately 200.
10. Servidei S: Mitochondrial encephalomyopathies: gene mutation. Neuromusc Disord 1997, 7:13-17. This is a periodically updated list of mitochondrial DNA mutations.
11. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
12. Holt IJ, Harding AE, Cooper JM, Schapira AHV, Toscano A, Clark JB, Morgan-Hughes JA: Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989, 26:699-708.
13. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S et al.: Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989, 320:1293-1299.
14. Brockington M, Sweeney MG, Hammans SR, Morgan-Hughes JA, Harding AE: A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nature Genet 1993, 4:67-71.
15. Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, Schon EA: Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995, 57:239-247.
16. De Coo IFM, Gussinklo T, Arts PJW, Van Oost BA, Smeets HJM: A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA for blood samples. J Neurol Sci 1997, 149:37-40. A potentially important paper suggesting that deletions causing KSS and CPEO can be detected in DNA from blood samples by 'long polymerase chain reaction'.
17. Zeviani M: Nucleus-driven mutations of human mitochondrial DNA. J Inherit Metab Dis 1992, 15:456-471.
18. Johns DR, Threlkeld AB, Miller NR, Hurko O: Multiple mitochondrial DNA deletions in myo-neuro-gastrointestinal encephalopathy syndrome. Am J Ophthalmol 1993, 115:108-109.
19. Suolamainen A, Kaukonen J, Amati P, Timonen R, Haltia M, Weissenbach J, Zeviani M, Somer H, Peltonen L: An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet 1995, 9:146-151.
20. Kaukonen JA, Amati P, Suomalainen A, Rötig A, Piscaglia MG, Salvi F, Weissenbach J, Fratta G, Comi G, Peltonen L, Zeviani M: An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996, 58:763-769. This paper and [19] provide data on loci in multiple mitochondrial DNA deletion syndrome. Identification of the genes responsible will be of great interest for our understanding of mitochondrial DNA control and replication.
21. Bohlega A, Tanji K, Santorelli FL, Hirano M, Al-Jashi A, DiMauro S: Multiple mtDNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996, 46:1329-1334. This study demonstrates the existence of autosomal recessive multiple mitochondrial DNA deletions.
22. Moslemi A-R, Melberg A, Holme E, Oldfors A: Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol 1996, 40:707-713 This study of single muscle fibres from patients of an autosomal dominant family with CPEO showed a clonal expansion of deletions.
23. Shoubridge EA: Autosomal dominant chronic progressive external ophthalmoplegia: a tale of two genomes. Ann Neurol 1996, 40:693-694.
24. Rahman S, Blok RB, Dahl HHM, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR: Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996, 39:343-351. A comprehensive review of the clinical, molecular genetic and biochemical correlations in a large series of Leigh's syndrome patients is presented.
25. Santorelli FM, Barmada MA, Pons R, Zhang LL, DiMauro S: Leigh-type neuropathy in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion. Neurology 1996, 47:1320-1323.
26. Keightley JA, Hoffbuhr KC, Buton MD, Salas VM, Johnston WSW, Penn AMW, Buist NRM, Kennaway NG: A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nature Genet 1996, 12:410-416. This is the first demonstration of a deletion confined to a cytochrome c oxidase gene.
27. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas LJ II, Nikoskelainen EK: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
28. Nikoskelainen EK, Savontaus M-L, Wanne OP, Katila MJ, Nummelin KU: Leber's hereditary optic neuroretinopathy, a maternally inherited disease. A geneologic study of four pedigrees. Arch Ophthalmol 1987, 105:665-671.
29. Johns DR: Genotypic-specific phenotypes in Leber hereditary optic neuropathy. Clin Neurosci 1994, 2:146-150.
30. Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC: Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 1996,16:771-777.
31. Shoffner JM, Brown MD, Stugard C, Jun AS, Pollock S, Laas RH, Kaufman A, Koontz D, Kim Y, Graham JR et al.: Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995, 38:163-169.
32. Riordan-Eva P, Sanders M, Govan GG, Sweeney MG, Da Costa J, Harding AE: The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995, 118:319-337.
33. Villki S, Savontaus ML, Aula P, Nikoskelainen EK: Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am H Hum Genet 1991, 48:486-491.
34. Newman NJ: Leber's hereditary optic neuropathy: new genetic considerations. Arch Neurol 1993, 50:540-548.
35. Chalmers RM, Davis MB, Sweeney M, Wood NW, Harding AE: Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet 1996, 59:103-108.
36. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P: Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995, 57:77-86.
37. Santorelli FM, Shanske S, Macaya A, De Vivo DC, DiMauro S: The mutation at nt8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993, 34:827-834.
38. Tatuch Y, Pagon RA, Vicek B, Roberts R, Korson M, Robinson BH: The 8993 mtDNA mutation: heteroplasmy and clinical presentation in three families. Eur J Hum Genet 1994, 2:35-43.
39. (B334) mutation of myoclonic epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992, 51:1201-1212.
40. Mariotti C, Saverese N, Suomalainen A, Rimoldi M, Comi G, Prelle A, Antozzi C, Servidei S, Jarre L, DiDonato S: Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995, 242:304-312
41. (3243) mutation: a clinical and genetic study. Brain 1995, 118:721-734.
42. Morgan-Hughes JA, Sweeney MG, Cooper JM, Hammans SR, Brockington M, Schapira AHV, Harding AE, Clark JB: Mitochondrial DNA (mt DNA) diseases: correlation of genotype to phenotype. Biochim Biophys Acta 1995, 1271:135-140.
43. De Vries D, de Wijs I, Ruitenbeek W, Begeer J, Smit P, Bentlage H, van Oost B: Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. J Neurol Sci 1994, 124:77-82.
44. (B344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Brain 1993, 116:617-632.
45. Hammans SR, Morgan-Hughes JA: Mitochondrial myopathies: clinical features, investigation, treatment and genetic counselling. In Mitochondrial Disorders in Neurology. Edited by Schapira AHV, DiMauro S. Oxford: Butterworth Heinemann; 1994:49-74.
46. Prezant TR, Agapian JV, Bohlman C, Bu X, Oztas S, Qiu W-Q, Arnos KS, Cortopassi GA, Jaber L, Rotter JI et al.: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet 1993, 4:289-294.
47. Pandya A, Xia X, Radnaabazar J, Batsuuri J, Dangaansuran B, Fischel-Ghodsian, Nane WE: Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet 1997, 34:169-172.
48. Moraes CT, Shanske S, Tritschler H-J, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S: Mt DNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991, 48:492-501.
49. Bodnar AG, Cooper JM, Holt IJ, Leonard JV, Schapira AHV: Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet 1993, 53:663-669.
50. Taanman J-W, Bodnar AG, Cooper JM, Morris AAM, Clayton PT, Leonard JV, Schapira AHV: Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum Mol Genet 1997, 6:935-942. This elegant set of experiments follows the sequence of events during the course of mitochondrial depletion, suggesting nuclear involvement in the process.